STRONG BUY. GALE definitely a target for ROCHE - confirmed in Forbes article.
Drug companies often don't disclose who's funding a drug study to avoid bias. IMO, It makes sense that Roche is doing what they're doing to protect Herceptin. If they're after patent protection then I can see them acquiring Neuvax and possibly combining it with Herceptin into a "new" patented product.
First quote from the Forbes article:
"Roth says it is encouraged by Galena’s strategic initiative to conduct a separate combination clinical trial of Neu Vax and Herceptin in 300 patients, funded by Galena, Roche, and the Henry M. Jackson Foundation."
This clears up the confusion in this thread about Roche's partnership with Galena. This is a second trial for Neuvax-- now in Phase 2. Obviously, there is some licensing agreement with Roche for Neuvax, used in conjunction with Herceptin. I have seen NO collateral licensing for Neuvax the Phase 3 trial--we dont need the money from Roche for this primary trial, best to keep them at arm's distance.
Second quote from the Forbes article:
"Neu Vax has the potential to be transcendent in the treatment of breast cancer, Ahn argues, assuming its late stage trials prove to be as effective as its early testing."
Why are we still under $2.00 a share?
The forbes article came out last month, this stock got filled with daytraders in march, drove it sky high, today,then thy got out. Today, people with no knowledge of Gale got spooked by dilution, and sold, that drove it down further. My take is, obviously the forbes article is very clear re Gale potential. Appears lots of savvy investors do too and jumped in this afternoon. Just my take. I got in in march, took some profit but not enough, but doubled down this morning. What is your take on it?
Why do we have to rely on Forbes article, or for that matter any other article to make our investment decisions?
Spend time and effort to conduct your own in-depth due diligence and you will be a better investor than them.
Forbes and other so call analysts are working for their own profits. They are offering their advice for free and for your benefits?
Since when that things offered for free carry any value?
You do not seem to understand whar DD is. When someone finds info, regardless of where, they are doing DD. Did you read posts from people today that had not heardof it before. I read it back in mid march, and bought gale primarily because of it. Today, we were getting hammered, I made a post requesting someone post a link as I do not know how. No one did, luckily I found the old post and updated it on the board. I think, along with several other factors, it helped gale recover today.GLTA
carmi, thanks for posting this article, it really gives you all you need to know about gale. When you mentioned to be needed by roche, in forbes, that should tell you what this is all about, ie billions of dollars. If you have not read, pease do so.